Quadron Announces Private Placement VANCOUVER, British

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
46
Quadron Announces Private Placement

VANCOUVER, British Columbia, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Quadron Cannatech Corporation (the “Company” or “Quadron”) - (CSE:QCC) is pleased to report it has arranged a non-brokered private placement of units of the Company at a price of twenty cents per unit for aggregate proceeds of up to $1 million.  Each unit consists of one common share of the Company and one-half of one common share purchase warrant, with each whole warrant entitling the holder to acquire an additional common share of the Company at a price of thirty cents for a period of thirty-six months from the date of issuance, subject to accelerated expiry in the event that the Company’s common shares close at a price of fifty cents or higher for ten consecutive trading days.

The Company will use the net proceeds of the offering for the manufacturing of extraction equipment for resale, the purchase of ancillary products for resale and for working capital purposes.

Rosy Mondin, President and CEO of Quadron reported, “We have identified an extremely large-scale market requiring modernized, more efficient, and automated processes in the extraction business.  Quadron's recently unveiled BOSS C02 extractor is the most cutting edge C02 extractor available in the market, highlighted by its simplicity and plug and play design.  We are already seeing very strong reception and expect our order book to grow rapidly.  This financing allows us to build out and deliver on our purchase orders in a fraction of the time of competitors and further market this next generation machine."

The Company may pay finders' fees to one or more arm's-length parties which introduce the Company to subscribers, in accordance with the policies of the Canadian Securities Exchange. The securities will be subject to a four-month-and-one-day statutory hold period from the date of issuance.  Closing of the private placement remains subject to the receipt of all regulatory approvals, including the approval of the Canadian Securities Exchange.

About Quadron: Quadron focuses on ancillary equipment, products and services for the authorized cannabis industry by providing a full array of end to end extraction and processing solutions including sales of alternative end user delivery options for recreational and medical consumers.

For more information, visit: www.quadroncannatech.com

On behalf of the Board of Directors of QUADRON CANNATECH CORPORATION

Rosy Mondin President and CEO rosy@quadroncannatech.com

Investor Relations Contact: KIN Communications Inc. Caleb Jeffries, VP, Investor Relations 1-866-684-6730 QCC@kincommunications.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as “forward-looking statements”.  Forward-looking statements may be identified by words including “anticipates”, “believes”, “intends”, “estimates”, “expects” and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company’s future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.  

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 5

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading

Top 5 Most Recently Viewed Articles

Great Hearts Introduces Services for Classical Education Support

Updated Category News Views 117

Great Hearts Launches New Support Services for Classical Schools Great Hearts, a leader in K-12 classical education, proudly announces the launch of Great Hearts Services. This new initiative aims to provide extensive instructional and operational support to classical schools throughout the country. The goal is not just to offer help but to partner with educational...

Continue Reading
Funding Boost Elevates Kindred's Home Swapping System

Updated Category News Views 211

Funding Announcement for Kindred In an exciting development, Kindred, a pioneering home swapping platform, has successfully raised $125 million to fuel its expansion. This substantial funding marks a significant step in establishing home swapping as a legitimate option in the travel industry, which has traditionally revolved around hotels and short-term rentals....

Continue Reading
Transforming Public Safety: Real-Time 9-1-1 Integration

Updated Category News Views 71

Revolutionizing Emergency Response with Technology Motorola Solutions (NYSE: MSI) is making significant strides in public safety by integrating real-time 9-1-1 intelligence into law enforcement's crime response systems. By funneling critical 9-1-1 call data directly into real-time crime centers (RTCCs), Motorola Solutions ensures that police can respond faster and more...

Continue Reading
Transformative Storytelling Retreat for Aspiring Leaders

Updated Category News Views 131

Introducing Story Camp™ by GhostRanch Communications GhostRanch Communications is excited to unveil Story Camp™, a retreat specifically designed for emerging leaders looking to enhance their presentation and storytelling skills. This inventive program aims to provide participants with the tools they need to elevate their communication and engage effectively with their...

Continue Reading
Leica's Big Move: What StatLab Means for Investors

Updated Category News Views 36

Leica Biosystems Sets Sights on StatLab There's a fresh chapter brewing in the niche of cancer diagnostics as Leica Biosystems, riding on the shoulders of Danaher, decides it's time to acquire StatLab. Consider this a big shake-up in the anatomic pathology playground. Leica is known for striding through the path of cancer diagnostics with aplomb, while StatLab brings to...

Continue Reading